Alessandro Perrella: It is Not Only about “How High the CRP is”, but “in Which Patient” We are Measuring That Value
Alessandro Perrella, Director of the Unit of Emerging and Highly Contagious Infectious Diseases at Ospedali dei Colli, Infectious Disease Specialist at Antonio Cardarelli National Referral Hospital, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Antibiotics, adding:
“In a panorama where we often look for a single, linear answer, this study conducted in the Department of Infectious Diseases and Emerging Infectious Diseases shows that even a key parameter like PCR and CRP can lose its meaning if we do not take into account the ‘background noise’ generated by chronic inflammatory comorbidities.
In other words, it is not only about ‘how high the CRP is’, but ‘in which patient’ we are measuring that value.
From this perspective, we developed a ‘Comorbidity Confounder Score‘ (CCS), built on physiopathological grounds, which isolates the subgroups in which CRP regains a good ability to distinguish bacterial from viral infections, while still remaining an exploratory tool that has not yet been validated for clinical use.
The paper published yesterday in Antibiotics also presents a prototype of a ‘POC‑CRP Assistant‘, a web app that automates CCS calculation and provides a contextualized interpretation of CRP values, designed to integrate with new point‑of‑care (POC) systems and ward workflows.
This is only the beginning of a journey toward integrating AI‑based tools into clinical practice, but it is important to start precisely by recognizing ‘visible’ confounders and building simple, transparent solutions that are integrated into everyday practice.
The goal is not to replace clinicians, but to support them in making more informed decisions.
A huge thank you to the entire working group, without whom all this would have been impossible: Prof. Paola Salvatore, Francesca Futura Bernardi, Pierpaolo Di Micco, Ugo Trama, Rita Boenzi, Antimo di Spirito, Claudia Tiberio, Giusy di Flumeri, Nicolina Capoluongo and Mariano Bernardo.
Stay tuned:
We will be back with new amazing AI‑based strategies in Infectious Disease.”
Title: The Confounder in Plain Sight: A Retrospective Pilot Analysis on the Impact of Comorbidity on C-Reactive Protein Utility for Differentiating Bacterial vs. Viral Infections
Authors: Alessandro Perrella, Paola Salvatore, Pierpaolo Di Micco, Ugo Trama, Antimo Di Spirito, Claudia Tiberio, Mariano Bernardo, Nicolina Capoluongo, Giusy Di Flumeri, Rita Boenzi, Francesca Futura Bernardi
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 13, 2026, 21:05Francisco Chacón-Lozsán: Heparin-Induced Thrombocytopenia – When an Anticoagulant Triggers Thrombosis
-
Oct 13, 2026, 21:04Aref Zribi: Isolated Tumor Thrombus and the Role of Prophylactic Anticoagulation
-
Oct 13, 2026, 21:01Alex Larson: Why Normal Bloodwork Does Not Always Tell the Whole Story
-
Oct 13, 2026, 20:58Juan Jauregui-Lozano: How Replication Stress Impairs Red Blood Cell Maturation
-
Oct 13, 2026, 20:55Caitlin Raymond: Understanding Platelet Refractoriness Before Ordering More Platelets
-
Oct 13, 2026, 20:54Sanja Seratlic: How Cow Feeding Systems Influence the Anti-Platelet Properties of Cheddar Cheese
-
Oct 13, 2026, 20:50Ruchika Goel: Cord Blood Red Blood Cells as a Physiologically Aligned Transfusion Strategy
-
Oct 13, 2026, 20:47Sophia Delicou: Strengthening Transfusion Safety Through Advanced Screening and Haemovigilance
-
Oct 13, 2026, 20:45Lydia Pecker: Alloimmunization and Transfusion Indications in Sickle Cell Disease Pregnancy